A quantification of myocardial blood flow using CT perfusion (CTP) imaging was strongly predictive of major adverse cardiac events (MACE) and offered additional prognostic ability when added to coronary CT angiography, researchers reported in JACC: Cardiovascular Imaging.
Researchers from Weill Cornell Medicine in New York are worried the extension of transcatheter aortic valve replacement (TAVR) to younger, intermediate-risk patients is outpacing clinical evidence.
A recent review of almost 80 randomized control trials suggests increased intake of long-chain omega-3 (LCn3) polyunsaturated fatty acids from oily fish have minimal to no effect on mortality or cardiovascular health. Results of the review were published online July 18 in the Cochrane Library.
Mitral valve operations are the fastest-growing type of heart procedure, according to an analysis of the Society of Thoracic Surgeons’ Adult Cardiac Surgery database—but researchers believe interventions at earlier stages could further improve outcomes.
The implementation of e-counseling, in addition to traditional medical therapy, improved systolic blood pressure, pulse pressure, and cardiovascular disease (CVD) risk reduction in the REACH (Reducing Risk with E-based support for Adherence to Lifestyle Change in Hypertension) trial.
Former President George H.W. Bush’s cardiologist was killed on July 20 in an apparent bicycle drive-by shooting near the Texas Medical Center (TMC) in Houston.
Percutaneous coronary intervention (PCI) patients who discharge against medical advice (DAMA) are twice as likely to be readmitted to the hospital, according to a new study published in JACC: Cardiovascular Interventions.
The American College of Cardiology (ACC) announced the selection of Timothy W. Attebery, MBA, to serve as its chief executive officer, effective Sept. 1.
Inferior vena cava (IVC) filter placement is associated with improved in-hospital mortality rates for patients admitted with congestive heart failure (CHF) and pulmonary embolism (PE), according to a new study published by the American Journal of Roentgenology.
Boston Scientific announced its acquisition of Santa Rosa, California-based Claret Medical in a transaction that includes $220 million upfront and an additional potential reimbursement-based milestone payment of up to $50 million. The deal is expected to close before the end of the year.
